Richard Mailloux, MD
Gastroenterology · Beckley, WVNPI 1215976188
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 368 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 41.8% of the total.
Across 368 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$956
- Pfizer$705
- Gilead$314
- Takeda Pharmaceuticals U.S.A., Inc.$268
- Bristol Myers Squibb$174
- plus $938 from 21 others
What the payments were for
- Food & beverage$5,66598%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 169 | $2,408 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 67 | $956 |
| Pfizer | 42 | $705 |
| Gilead | 18 | $314 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $268 |
| Bristol Myers Squibb | 11 | $174 |
| Ardelyx, Inc. | 7 | $158 |
| Johnson & Johnson | 4 | $145 |
| Phathom Pharmaceuticals, Inc. | 4 | $86 |
| Redhill Biopharma Inc. | 5 | $63 |
| Merck | 4 | $57 |
| Ferring Pharmaceuticals Inc. | 3 | $55 |
| Novo Nordisk | 2 | $39 |
| Lilly USA, LLC | 2 | $39 |
| Axonics, Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $34 |
| Sandoz | 2 | $34 |
| QOL Medical, LLC | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Celltrion USA Inc. | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Sanofi | 1 | $13 |
| UCB, Inc. | 1 | $12 |
How this compares
$5,764 in reported general payments places this provider in the 70th percentile of 72 gastroenterology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 20 | $192,420 |
| Budesonide DrBudesonide | 12 | $3,705 |
| Mesalamine | 12 | $2,955 |
| Pantoprazole Sodium | 186 | $1,494 |
| Omeprazole | 110 | $1,378 |
| LoperamideLoperamide Hcl | 28 | $1,245 |
| Ondansetron OdtOndansetron | 11 | $219 |
| Amitriptyline Hcl | 11 | $119 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Beckley
- Sardar Shah-KhanBeckley$27K
- Charles Bou-AbboudBeckley$1K
- Angela DolganiucBeckley$1K
- Husam NazerBeckley$1K
- Touraj FaridBeckley$311
- Jennifer VeverkaMorgantown$283K
- Shailendra SinghMorgantown$187K
- Mohamad HaffarSouth Charleston$118K
- Shyam ThakkarMorgantown$113K
- Hazem Al-AshhabParkersburg$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.